FHI 360: Clinical Trials

6 trials sponsored by FHI 360, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 6

Follow FHI 360: new trials by email

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Acceptability of the PrePex™ Device for Male Circumcision in Zambia
PrePex - HIV
Phase 4CompletedFHI 3605002013-10-012014-05-13
A Prospective Field Study: Introducing the Shang Ring in Routine Clinical Settings
Shang Ring - Male Circumcision
Phase 4CompletedFHI 36012002012-02-012012-09-27
Long-Acting Reversible Contraception
DMPA, oral contraceptives, Implanon® - Contraception
Phase 4CompletedFHI 3609162011-12-012018-02-28
In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican Children
Coartem™ (Artemether-lumefantrine combination), Coarsucam™ (Amodiaquine-artesunate combination) - Malaria
Phase 4CompletedCentro de Investigacao em Saude de Manhica7002011-06-012014-06-20
Interactions Between Antiretrovirals (ARVs) and Combined Oral Contraceptives (COCs)
ETHINYL ESTRADIOL AND LEVOGESTREL - HIV/AIDS, HIV Infections
Phase 4CompletedFHI 3603702009-03-012011-10-31
Continuous Use of COCs
Oral contraceptives--ethinyl estradiol, levonorgestrel - Pregnancy Prevention
Phase 4CompletedFHI 3603622007-08-012011-10-31

Conditions studied

Acquired Immunodeficiency Syndrome (2)  ·  HIV Infections (1)  ·  Malaria (1)

Interventions

Ethinyl Estradiol (2)  ·  Levonorgestrel (2)  ·  Artemether, Lumefantrine Drug Combination (1)  ·  Contraceptives, Oral (1)  ·  N,N-dimethyl-4-anisidine (1)  ·  amodiaquine, artesunate drug combination (1)  ·  etonogestrel (1)

Countries

Zambia (2)  ·  Dominican Republic (1)  ·  Kenya (1)  ·  Mozambique (1)  ·  Nicaragua (1)  ·  South Africa (1)  ·  Uganda (1)  ·  United States (1)

Top investigators

Bruce Bvulani, MBChB, MMed (1)  ·  David Hubacher, PhD (1)  ·  Jared Mogouche, MD ChB (1)  ·  John M Wekesa, MB ChB MMed (1)  ·  Karin Hatzold, MD, Ph.D. (1)  ·  Kasonde Bowa, MSc M. Med FRCS FACS FCS (1)  ·  Kavita Nanda, MD (1)  ·  Kavita Nanda, MD, MHS (1)  ·  Marc Goldstein, M.D. (1)  ·  Mark A Barone, DVM, MS (1)  ·  Namwinga Chintu, MBChB (1)  ·  Nicholas Muraguri, MB ChB MPH (1)  ·  Paul Hewett, Ph.D. (1)  ·  Paul Perchal, MA (1)  ·  Philip S Li, MD (1)

Results publications

PMID 24088680, PMID 24785854, PMID 26367141, PMID 27331585, PMID 29470950, PMID 29920171